Drug · DIN 02533200
MIDODRINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 31, 2023; first marketed May 31, 2023.
- Drug Identification Number (DIN)
- 02533200
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Midodrine C01CA17
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MIDODRINE HYDROCHLORIDE | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 1, 2022: NOC 29603Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
Other DINs named MIDODRINE
- DIN 02533219 · Marketed